Summit Securities Group’s Sanofi SNY Stock Holding History

Summit Securities Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.9K	Buy	+1,100	New	+$49.2K	﹤0.01%	595
2025 Q4	–	Sell	-96,355	Closed	-$4.55M	–	1235
2025 Q3	$4.55M	Buy	96,355 +65,868	+216%	+$3.18M	0.94%	21
2025 Q2	$1.47M	Sell	30,487 -11,193	-27%	-$572K	0.28%	72
2025 Q1	$2.31M	Buy	+41,680	New	+$2.26M	0.36%	33
2023 Q4	–	Sell	-130,183	Closed	-$6.98M	–	888
2023 Q3	$6.98M	Buy	130,183 +101,430	+353%	+$5.41M	0.72%	27
2023 Q2	$1.55M	Sell	28,753 -148,883	-84%	-$8.01M	0.2%	72
2023 Q1	$9.67M	Buy	177,636 +177,436	+88,718%	+$8.63M	0.79%	26
2022 Q4	$10K	Hold	200	–	–	﹤0.01%	1034
2022 Q3	$8K	Hold	200	–	–	﹤0.01%	810
2022 Q2	$10K	Buy	+200	New	+$10.6K	﹤0.01%	839
2016 Q3	–	Sell	-17,000	Closed	-$711K	–	256
2016 Q2	$711K	Buy	+17,000	New	+$697K	0.38%	59
2015 Q3	–	Sell	-1,500	Closed	-$74K	–	505
2015 Q2	$74K	Buy	+1,500	New	+$76K	0.04%	155
2014 Q3	–	Sell	-100	Closed	-$5K	–	791
2014 Q2	$5K	Buy	+100	New	+$5.31K	﹤0.01%	441

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Summit Securities Group's SNY Position: Q2 2026 in Review

Summit Securities Group opened a new position in Sanofi (SNY) in Q2 2026: 1,100 shares worth $46.9K. The stake represents ﹤0.01% of the portfolio and ranks #595 among its holdings. This is a return to the name: Summit Securities Group previously reported a position in SNY as recently as Q3 2025.

Summit Securities Group first reported a position in SNY in Q2 2014 and has held it in 13 quarters since. The position peaked at $9.67M in Q1 2023. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Summit Securities Group held 1,100 shares of Sanofi worth $46.9K as of Q2 2026.
Sanofi was a new Summit Securities Group position in Q2 2026.
Sanofi made up ﹤0.01% of Summit Securities Group's portfolio in Q2 2026, its #595 holding.
Summit Securities Group first reported a position in Sanofi in Q2 2014 and has held it in 13 quarters since.
Summit Securities Group's Sanofi position peaked at $9.67M in Q1 2023.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.